We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+1.01%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.17B
AUM Growth
+$137M
Cap. Flow
+$273M
Cap. Flow %
23.33%
Top 10 Hldgs %
50.6%
Holding
152
New
28
Increased
32
Reduced
40
Closed
19

Top Buys

Rank Stock Value
1
ASRT
Assertio
ASRT
+$18.2M
2
CRMT icon
America's Car Mart
CRMT
+$13M
3
PTON icon
Peloton Interactive
PTON
+$12.7M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$11.5M
5
NDLS icon
Noodles & Co
NDLS
+$7.52M

Top Sells

Rank Stock Value
1
TBBK icon
The Bancorp
TBBK
+$14M
2
AUTL
Autolus Therapeutics
AUTL
+$10.2M
3
CASH icon
Pathward Financial
CASH
+$8.42M
4
MAX icon
MediaAlpha
MAX
+$8.11M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$6.53M

Sector Composition

Rank Sector Weight
1 Healthcare 36.11%
2 Consumer Discretionary 9.31%
3 Financials 6.27%
4 Communication Services 5.51%
5 Technology 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AYTU icon
76
AYTU BioPharma
AYTU
$25.9M
$2.93M 0.25%
1,086,812
– –
SNDX icon
77
CALL
Syndax Pharmaceuticals
SNDX
$1.81B
$2.9M 0.25%
+200,000
New +$3.78M
ENVA icon
78
Enova International
ENVA
$6.4B
$2.71M 0.23%
53,250
– –
PWP icon
79
Perella Weinberg Partners
PWP
$1.32B
$2.63M 0.22%
258,273
– –
RILY icon
80
BRC Group Holdings
RILY
$294M
$2.56M 0.22%
62,520
– –
NNBR icon
81
NN Inc
NNBR
$315M
$2.52M 0.22%
1,353,143
+827,137
+157% +$1.94M
TARS icon
82
Tarsus Pharmaceuticals
TARS
$2.99B
$2.41M 0.21%
+135,500
New +$2.4M
CDTX
83
DELISTED
Cidara Therapeutics
CDTX
$2.39M 0.2%
126,920
-71,175
-36% -$1.4M
ELUT icon
84
Elutia
ELUT
$35.4M
$2.36M 0.2%
+1,650,000
New +$2.89M
RNAC icon
85
Cartesian Therapeutics
RNAC
$259M
$2.33M 0.2%
73,333
+40,000
+120% +$1.34M
FOSL icon
86
Fossil Group
FOSL
$309M
$2.03M 0.17%
985,215
+65,035
+7% +$152K
IMTXW
87
DELISTED
Immatics N.V. Warrants
IMTXW
$1.98M 0.17%
558,977
-427,124
-43% -$1.51M
SSKN
88
DELISTED
Strata Skin Sciences
SSKN
$1.94M 0.17%
326,495
-112,874
-26% -$867K
MAX icon
89
MediaAlpha
MAX
$804M
$1.94M 0.17%
234,372
-908,613
-79% -$8.11M
CCCC icon
90
C4 Therapeutics
CCCC
$421M
$1.86M 0.16%
1,000,000
– –
FBIO icon
91
Fortress Biotech
FBIO
$87.4M
$1.75M 0.15%
401,214
-24,833
-6% -$170K
SRL icon
92
Scully Royalty
SRL
$87.7M
$1.69M 0.14%
298,491
-5,245
-2% -$33.7K
JSPR icon
93
Jasper Therapeutics
JSPR
$31.1M
$1.68M 0.14%
240,290
-7,498
-3% -$91.5K
ANEB
94
DELISTED
Anebulo Pharmaceuticals
ANEB
$1.56M 0.13%
511,073
– –
EHTH icon
95
CALL
eHealth
EHTH
$39.7M
$1.5M 0.13%
203,100
– –
AAN
96
DELISTED
The Aaron's Company Inc
AAN
$1.45M 0.12%
138,572
– –
JBIO
97
Jade Biosciences
JBIO
$1.34B
$1.29M 0.11%
2,714
– –
TGTX icon
98
TG Therapeutics
TGTX
$7.61B
$1.25M 0.11%
+150,000
New +$2.09M
RDNW
99
CALL
RideNow Group
RDNW
$244M
$1.23M 0.1%
200,000
-300,000
-60% -$2.42M
NGNE icon
100
Neurogene
NGNE
$690M
$1.18M 0.1%
+75,000
New +$1.11M
2 3
4
5 6

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Nantahala Capital Management held 152 positions worth $1.17B, up 13% from $1.03B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Nantahala Capital Management deployed $273M of net new capital in Q3 2023, opening 28 new positions and adding to 32 existing holdings. Its largest new stake was Assertio: 311,333 shares worth $12M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 41% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was The Bancorp, an estimated $14M trimmed.

  • Nantahala Capital Management's largest Q3 2023 buy was Assertio: 311,333 shares worth $12M.
  • Nantahala Capital Management added most to America's Car Mart in Q3 2023, an estimated $13M increase.
  • Nantahala Capital Management's biggest Q3 2023 reduction was The Bancorp, cutting an estimated $14M.
  • Nantahala Capital Management fully exited Autolus Therapeutics in Q3 2023, selling an estimated $10.2M.
  • Nantahala Capital Management's ten largest holdings make up 51% of its $1.17B portfolio in Q3 2023.
  • Nantahala Capital Management opened 28 new positions and closed 19 in Q3 2023.
  • Nantahala Capital Management's portfolio value rose 13% quarter-over-quarter to $1.17B.

Based on Nantahala Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.